Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS AUROBINDO PHARMA IPCA LABS/
AUROBINDO PHARMA
 
P/E (TTM) x 51.7 23.0 225.1% View Chart
P/BV x 5.4 2.4 226.1% View Chart
Dividend Yield % 0.3 0.3 117.3%  

Financials

 IPCA LABS   AUROBINDO PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
AUROBINDO PHARMA
Mar-23
IPCA LABS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,062715 148.6%   
Low Rs768397 193.3%   
Sales per share (Unadj.) Rs243.0424.2 57.3%  
Earnings per share (Unadj.) Rs19.432.9 58.9%  
Cash flow per share (Unadj.) Rs29.754.1 54.9%  
Dividends per share (Unadj.) Rs4.003.00 133.3%  
Avg Dividend yield %0.40.5 81.0%  
Book value per share (Unadj.) Rs230.3458.1 50.3%  
Shares outstanding (eoy) m253.70585.94 43.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.81.3 287.3%   
Avg P/E ratio x47.216.9 279.2%  
P/CF ratio (eoy) x30.810.3 300.0%  
Price / Book Value ratio x4.01.2 327.4%  
Dividend payout %20.69.1 226.2%   
Avg Mkt Cap Rs m232,120325,753 71.3%   
No. of employees `000NANA-   
Total wages/salary Rs m12,87635,223 36.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,642248,554 24.8%  
Other income Rs m1,5182,906 52.2%   
Total revenues Rs m63,160251,460 25.1%   
Gross profit Rs m9,03337,070 24.4%  
Depreciation Rs m2,61612,446 21.0%   
Interest Rs m4821,405 34.3%   
Profit before tax Rs m7,45326,125 28.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5346,849 37.0%   
Profit after tax Rs m4,91919,277 25.5%  
Gross profit margin %14.714.9 98.3%  
Effective tax rate %34.026.2 129.7%   
Net profit margin %8.07.8 102.9%  
BALANCE SHEET DATA
Current assets Rs m51,893214,599 24.2%   
Current liabilities Rs m18,058114,938 15.7%   
Net working cap to sales %54.940.1 136.9%  
Current ratio x2.91.9 153.9%  
Inventory Days Days5121 248.4%  
Debtors Days Days666 8.9%  
Net fixed assets Rs m34,336176,668 19.4%   
Share capital Rs m254586 43.3%   
"Free" reserves Rs m58,167267,813 21.7%   
Net worth Rs m58,420268,399 21.8%   
Long term debt Rs m6,5186,190 105.3%   
Total assets Rs m86,229392,125 22.0%  
Interest coverage x16.519.6 84.0%   
Debt to equity ratio x0.10 483.8%  
Sales to assets ratio x0.70.6 112.8%   
Return on assets %6.35.3 118.8%  
Return on equity %8.47.2 117.2%  
Return on capital %12.210.0 121.9%  
Exports to sales %42.933.7 127.3%   
Imports to sales %13.315.3 86.6%   
Exports (fob) Rs m26,43483,703 31.6%   
Imports (cif) Rs m8,17838,060 21.5%   
Fx inflow Rs m26,43485,483 30.9%   
Fx outflow Rs m8,17841,447 19.7%   
Net fx Rs m18,25744,036 41.5%   
CASH FLOW
From Operations Rs m8,05823,868 33.8%  
From Investments Rs m-7,250-39,778 18.2%  
From Financial Activity Rs m5,07218,144 28.0%  
Net Cashflow Rs m5,8812,298 255.9%  

Share Holding

Indian Promoters % 46.3 48.8 94.9%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 44.8 41.3 108.4%  
FIIs % 10.3 20.7 49.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 48.2 111.5%  
Shareholders   82,809 241,944 34.2%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs Aurobindo Pharma Share Price Performance

Period IPCA Labs Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 3.35% 1.82% 1.18%
1-Month 4.27% 5.96% -0.75%
1-Year 56.49% 113.07% 61.82%
3-Year CAGR 9.46% 7.78% 18.16%
5-Year CAGR 20.88% 7.18% 19.79%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.